Abstract

Cancer Vaccines 2015 will strengthen knowledge of targeted immunotherapies taking the foreground in revolutionizing cancer vaccines, as well as look at the practicalities towards achieving sustained immune response. SMi Group have worked closely with a leading panel of experts such as GSK Vaccines, Vaccinogen, National Cancer Institute and Kings College London, to create a programme that will expand scientific horizons in topics such as formulation development, tumour genetic heterogeneity, personalized treatment, combination therapies, gene editing for immunotherapy, plus more!